Investors and shareholders

All the information you need about Fagron as an investment

H1 2025 Results

Fagron Capital Markets Day

Management's insights into Fagron’s strategic plan and medium term financial objectives for the period 2025-30.

READ MORE
Fagron Capital Markets Day

Document 1

Explore this document!

PDF Icon Fagron-annual-report-2023-FINAL

One Global Fagron

Explore Fagron

Calendar

Calendar

Find out about upcoming events

Read more
Fagron personalizing medicine

ESG

ESG

Read the latest ESG updates

Read more
Fagron personalizing medicine

Press Release

Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America

See latest press release

Read more

FAGRON

Board of Directors

Learn more about our Board of Directors

Learn more
Fagron personalizing medicine

Fagron at a glance

Year 2022

Revenue
€684m
REBITDA
€131m
Net Result
€70m

One Global Fagron

Grid 2 (new)

Grid 2 (new)

Link

Calendar

Calendar

Calendar

Homepage
Fagron personalizing medicine

Calendar

Calendar

Calendar

Homepage
Fagron personalizing medicine

Press Release

Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America

See latest press release

Read more

Calendar

Calendar

Calendar

Homepage
Fagron personalizing medicine

Annual Report Archive

Read our Annual Reports

See all Annual Reports

Contact

If you would like to receive more information about Fagron, please contact Investor Relations.

Contact

To receive our press releases please sign up here

Subscribe